Drug intelligence / Profile preview

PreCold

Development stage
Unknown
Lead developer
Intas Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

PreCold is a fixed-dose combination pharmaceutical product marketed primarily in India for the symptomatic relief of the common cold and associated upper respiratory conditions. The medication integrates three active ingredients: paracetamol, phenylpropanolamine, and cetirizine. Paracetamol serves as an analgesic and antipyretic by inhibiting prostaglandin synthesis, primarily within the central nervous system, to reduce pain and fever. Phenylpropanolamine is a sympathomimetic amine that acts as a nasal decongestant by stimulating alpha-adrenergic receptors, leading to vasoconstriction of the nasal mucosa and reduction of swelling. Cetirizine is a second-generation antihistamine that provides relief from allergic symptoms such as sneezing, runny nose, and watery eyes by selectively antagonizing peripheral H1 receptors. Together, these components address the multi-symptom nature of viral respiratory infections and allergic rhinitis.

Brand names
PreCold
02

Targets

HRH1 (Histamine H1 Receptor)ADRA1A (α1A)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on PreCold.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PreCold.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call